Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Dentsply Sirona adds two industry veterans to its board
CHARLOTTE, N.C. - Dentsply Sirona Inc. (NASDAQ:XRAY), a global leader in dental products and technologies, has announced the ...
Target hit with class action lawsuit claiming they misled investors over DEI policies
Target’s stock price plummeted 22% on Nov. 20, 2024, destroying nearly $16 billion in market cap in a single day after the ...
STAT7h
FDA clinical trial inclusivity guidelines will be back
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The National Law Review7h
Legislators Introduce Feed Lot Testing Bill
Senator Cory Booker and Representative Rosa DeLauro introduced a bill to provide FDA the authority to collect microbial ...
RenovoRx Announces Proposed Public Offering
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery ...
Probable causes of CTA Yellow Line crash revealed by NTSB
The National Transportation Safety Board released findings from its investigation into the CTA Yellow Line crash that left 19 wounded in 2023.